Testing of the Drug Tranexamic Acids as Prophylaxis of Bleeding in Benign Surgical Removal of the Uterus
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
In Denmark, 4400 women annually undergo hysterectomy on benign background (surgical removal
of the uterus). 10% of these women experience bleeding complications. The drug Tranexamic
Acid (Cyklokapron) has showed significant reduction of bleeding in relation to other types of
surgery. The hypothesis of this study is that Tranexamic Acid could also reduce the operative
bleeding associated with benign hysterectomy. The study will be carried out as a randomized,
placebo-controlled national multicenter trial
Phase:
Phase 4
Details
Lead Sponsor:
Hillerod Hospital, Denmark
Collaborators:
Central Denmark Region Odense University Hospital Research grant from Nordsjællands Hospital Rigshospitalet, Denmark The Danish hysterectomy and hysteroscopy database The fund of Olga Bryde